Invesco Ltd. Xeris Biopharma Holdings, Inc. Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 86,194 shares of XERS stock, worth $629,216. This represents 0.0% of its overall portfolio holdings.

Number of Shares

86,194

Previous 1,026,838 91.61%

Holding current value

$629,216

Previous $5.64 Million 92.87%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$3.95 - $5.16 $3.72 Million - $4.85 Million	-940,644 Reduced 91.61%	86,194 $402,000
Q1 2025 May 12, 2025	BUY	$3.2 - $5.95 $3.07 Million - $5.7 Million	957,822 Added 1387.83%	1,026,838 $5.64 Million
Q4 2024 Feb 13, 2025	BUY	$2.78 - $3.73 $3,752 - $5,035	1,350 Added 2.0%	69,016 $233,000
Q3 2024 Nov 12, 2024	BUY	$2.06 - $2.96 $2,342 - $3,365	1,137 Added 1.71%	67,666 $192,000
Q2 2024 Aug 13, 2024	BUY	$1.7 - $2.45 $4,635 - $6,681	2,727 Added 4.27%	66,529 $149,000
Q1 2024 May 14, 2024	BUY	$2.04 - $3.22 $1,275 - $2,012	625 Added 0.99%	63,802 $141,000
Q4 2023 Feb 12, 2024	SELL	$1.47 - $2.36 $377,012 - $605,271	-256,471 Reduced 80.24%	63,177 $148,000
Q3 2023 Nov 13, 2023	SELL	$1.8 - $2.69 $3.21 Million - $4.8 Million	-1,784,974 Reduced 84.81%	319,648 $594,000
Q2 2023 Aug 11, 2023	BUY	$1.82 - $2.98 $4,158 - $6,809	2,285 Added 0.11%	2,104,622 $5.51 Million
Q1 2023 May 12, 2023	BUY	$1.03 - $1.63 $2,344 - $3,709	2,276 Added 0.11%	2,102,337 $3.43 Million
Q4 2022 Feb 13, 2023	SELL	$1.14 - $1.65 $7,973 - $11,540	-6,994 Reduced 0.33%	2,100,061 $2.79 Million
Q3 2022 Nov 14, 2022	BUY	$1.37 - $1.93 $9,383 - $13,218	6,849 Added 0.33%	2,107,055 $3.29 Million
Q2 2022 Aug 15, 2022	BUY	$1.48 - $2.64 $92,967 - $165,834	62,816 Added 3.08%	2,100,206 $3.23 Million
Q1 2022 May 16, 2022	BUY	$2.0 - $2.87 $2,528 - $3,627	1,264 Added 0.06%	2,037,390 $5.22 Million
Q4 2021 Feb 14, 2022	BUY	$1.8 - $2.93 $3.67 Million - $5.97 Million	2,036,126 New	2,036,126 $5.97 Million

Others Institutions Holding XERS

# of Institutions

206

Shares Held

89.5M

Call Options Held

81.6K

Put Options Held

57.6K

View Full List

About Xeris Biopharma Holdings, Inc.

Ticker XERS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,956,992
Market Cap $992M
Description
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...

More about XERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account